Specifically, estradiol alleviates virus-induced immunopathology by downregulating the expression of pro-inflammatory cytokines such as TNF-α, IL-6, and CCL2, thereby mitigating excessive pulmonary inflammation and improving infection outcomes [45,46]. Here, CCL2 is linked to infection.